Elevated levels of IL-6 have been found to play a pathological role in rheumatoid and juvenile idiopathic arthritis (RA and JIA, respectively), systemic lupus erythematosus (SLE), multiple sclerosis (MS), inflammatory bowel disease (IBD), and allergic asthma (60). Here, IL6 is linked to inflammatory bowel disease.